| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |